Edwards Lifesciences (EW) Non-Current Assets (2009 - 2026)

Edwards Lifesciences has reported Non-Current Assets for 18 years, with the latest figure at $7.0 billion in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 1.98% year-over-year to $7.0 billion in Q2 2026; TTM through Jun 2026 was $28.0 billion, a 4.78% increase from a year earlier, with the FY2025 full-year figure at $7.0 billion, up 2.78% from the prior year.
• Non-Current Assets was $7.0 billion for Q2 2026 at Edwards Lifesciences, down from $7.1 billion in the prior quarter.
• The five-year high for Non-Current Assets was $7.1 billion in Q1 2026, with the low at $5.1 billion in Q3 2022.
• Average Non-Current Assets over 5 years is $6.0 billion, with a median of $5.6 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets declined 2.35% in 2022, then gained 27.07% in 2024.
• Over 5 years, Non-Current Assets stood at $5.2 billion in 2022, then rose by 2.52% to $5.3 billion in 2023, then climbed by 27.07% to $6.8 billion in 2024, then gained by 2.78% to $7.0 billion in 2025, then gained by 1.29% to $7.0 billion in 2026.
• The last three Non-Current Assets figures came in at $7.0 billion (Q2 2026), $7.1 billion (Q1 2026), and $7.0 billion (Q4 2025), per Business Quant data.